Clinical trials: Pediculoses
Head Lice
Dermal Safety Study to Evaluate Potential Irritation of Abametapir Lotion
The purpose of the study is to determine the irritation potential of repeat applications of abametapir lotion on normal skin.
- Trial name
- NCT02061813
- Testing
- Abametapir Lotion 0.74% w/w, Sodium Lauryl Sulfate, Saline 0.9%
- Where
- United States
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- Dr. Reddy's Laboratories Limited
Head Lice, Pediculosis Capitis
A Clinical Trial to Evaluate Efficacy and Safety of a Water-soluble Head Lice Product.
The present study is set-up to compare in vivo clinical performance and safety of the test product versus an in the US commercially available, pyrethrum-based product (RID® shampoo).
- Trial name
- NCT03617926
- Testing
- X92001666
- Where
- 2 sites in United States
- Volunteers
- 70 people, healthy volunteers welcome
- Sponsor
- Oystershell NV
Pediculosis
An Efficacy and Safety Study of Ha44 Gel Administered Topically for the Treatment of Head Lice Infestation
Phase 2 study to assess the safety and effectiveness of a product to treat children and adults with head lice
- Trial name
- NCT01336647
- Testing
- Group A - Low-Dose Ha44 0.37% w/w, Group B - High Dose Ha44 Gel 0.74% w/w
- Where
- 2 sites in United States
- Volunteers
- 142 people
- Sponsor
- Dr. Reddy's Laboratories Limited
Head Lice Infestation
A Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation
The purpose of the study was to assess the efficacy, safety and tolerability of a single application of abametapir lotion 0.74% w/w compared to a vehicle control, when applied to the scalp and hair for 10 minutes at home.
- Trial name
- NCT02060903
- Testing
- Abametapir Lotion 0.74% w/w, Vehicle Lotion
- Where
- 7 sites in United States
- Volunteers
- 379 people
- Sponsor
- Dr. Reddy's Laboratories Limited
Pediculosis
Pharmacokinetic (PK) and Tolerance Study of Natroba Topical Suspension in Pediatrics With an Active Head Lice Infestation
A pharmacokinetic and tolerance study of Natroba (spinosad) Topical Suspension, 0.9% in pediatric subjects 6 months to 4 years of age with an active head lice infestation.
- Trial name
- NCT01660321
- Testing
- spinosad
- Where
- 2 sites in United States
- Volunteers
- 26 people
- Sponsor
- ParaPRO LLC
Head Lice
A Clinical Endpoint Bioequivalence Study to Assess Efficacy and Safety of Ivermectin 0.5% Lotion in the Treatment of Head Lice
This is a phase 3 randomized, multi-center, double-blind, placebo controlled, parallel group design study.
- Trial name
- NCT03337490
- Testing
- Ivermectin 0.5% Topical Application Lotion, Ivermectin 0.5% Topical Application Lotion [SKLICE]
- Where
- 6 sites in United States
- Volunteers
- 296 people
- Sponsor
- Mayne Pharma International Pty Ltd
Head Lice
Clinical Endpoint Study of Ivermectin 0.5% Lotion
This clinical study is designed to evaluate the clinical (therapeutic) effect of a generic ivermectin lotion 0.5% (Actavis Laboratories UT, Inc.) relative to that of the Food and Drug Administration (FDA) Reference Listed Drug…
- Trial name
- NCT03301649
- Testing
- Generic Ivermectin Lotion 0.5%, Sklice® (Ivermectin) Lotion 0.5%, Vehicle Lotion
- Where
- United States
- Volunteers
- 905 people, healthy volunteers welcome
- Sponsor
- Actavis Inc.
Head Lice
A Safety and Efficacy Study Comparing 0.5% Ivermectin Cream to a Vehicle Control in Subjects With Head Lice Infestation
The purpose of this study is to determine if 0.5% Ivermectin Cream is a safe and effective treatment for head lice infestations.
- Trial name
- LICE OUT (NCT01066585)
- Testing
- Ivermectin Cream, vehicle control
- Where
- 8 sites in United States
- Volunteers
- 410 people
- Sponsor
- Topaz Pharmaceuticals Inc
Pediculosis
Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice
In this study, Malathion Gel 0.5% will be compared to Nix (permethrin 1%) as a treatment for head lice in patients 2 years of age and older. Malathion Gel 0.5% is a new formulation of an established head lice treatment.
- Trial name
- NCT00963508
- Testing
- Malathion gel 0.5%, Permethrin 1% rinse (Nix Crème)
- Where
- 7 sites in United States
- Volunteers
- 403 people
- Sponsor
- Sun Pharmaceutical Industries, Inc.
Pediculosis Capitis
Efficacy and Safety of Licefreee Spray Against Nix 1% Permethrin
The purpose of this study is to evaluate the safety and efficacy of Licefreee Spray in eradicating head lice as compared to Nix, both are available over-the-counter lice treatments.
- Trial name
- NCT01514513
- Testing
- Licefreee Spray, 1% permethrin creme rinse
- Where
- United States
- Volunteers
- 42 people, healthy volunteers welcome
- Sponsor
- South Florida Family Health and Research Centers
Head Lice Infestation
Safety and PK Study of Ha44 Gel Under Maximal Use Conditions for Treatment of Head Lice Infestation
The purpose of the study is to evaluate the safety and tolerability of a single application of Ha44 Gel 0.74% w/v for the treatment of head lice under maximal use conditions.
- Trial name
- NCT01907490
- Testing
- Ha44 Gel
- Volunteers
- 38 people
- Sponsor
- Dr. Reddy's Laboratories Limited
Head Lice
Study Comparing the Safety and Efficacy of 0.5% Ivermectin Cream to Placebo in Lice Infested Subjects
The purpose of this study is to compare the safety and efficacy of a 0.5% ivermectin cream to a placebo in subjects infested with head lice when used in an "at home" environment.
- Trial name
- NCT00994422
- Testing
- Ivermectin cream, vehicle control
- Where
- 12 sites in United States
- Volunteers
- 264 people
- Sponsor
- Topaz Pharmaceuticals Inc
Pediculosis
Study to Evaluate the Effect of Ha44 Gel on the Electrocardiogram in Healthy Volunteers
The purpose of this study is to Evaluate the Effect of Ha44 Gel on the Electrocardiogram in Healthy Volunteers.
- Trial name
- NCT01518699
- Testing
- Ha44, Moxifloxacin
- Where
- United States
- Volunteers
- 57 people, healthy volunteers welcome
- Sponsor
- Dr. Reddy's Laboratories Limited
Pediculosis
Safety and Tolerability of a Novel Malathion Formulation in Children Age 6-24 Months With Head Lice
In a previous phase II study, the safety and efficacy of a novel formulation of malathion 0.5% was evaluated in patients 2 years of age and older.
- Trial name
- NCT00752973
- Testing
- MALG (malathion) Treatment
- Where
- 2 sites in United States
- Volunteers
- 12 people
- Sponsor
- Sun Pharmaceutical Industries, Inc.
Pediculus Capitis Infestation
Safety and Efficacy Study of NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects 6 Months or Older With Head Lice
A comparative safety and efficacy study of NatrOVA Creme Rinse - 1% versus NIX Creme Rinse, under actual use conditions in subjects 6 months of age or greater who are infested with Pediculosis capitis (Head lice).
- Trial name
- NCT00545168
- Testing
- Spinosad, Permethrin 1%
- Where
- 6 sites in United States
- Volunteers
- 480 people, healthy volunteers welcome
- Sponsor
- ParaPRO LLC
Pediculus Capitis
A Clinical Trial Evaluating the Efficacy of Resultz Lice and Egg Elimination Kit on Pediatric and Adult Subjects
A one day study to demonstrate that Resultz Lice and Egg Elimination Kit is statistically superior to a sham control with one hour of combing.
- Trial name
- NCT02997904
- Testing
- Apply Liquid Then Comb Out
- Where
- United States
- Volunteers
- 100 people
- Sponsor
- Piedmont Pharmaceuticals, LLC
Head Lice
A Pharmacokinetics (PK) Study in Lice Infested Children 6 Months to 3 Years of Age
The purpose of this study is to determine the bioavailability of 0.5% ivermectin cream in a pediatric population aged 6 months to 3 years.
- Trial name
- NCT00988533
- Testing
- 0.5% Ivermectin Cream
- Where
- 5 sites in United States
- Volunteers
- 30 people
- Sponsor
- Topaz Pharmaceuticals Inc
Head Lice
Bioequivalence Study for Benzyl Alcohol Lotion 5%.
To establish the therapeutic equivalence and safety of a generic Benzyl Alcohol Lotion 5% with Ulesfia Lotion 5% in eradication of head lice in the study subjects.
- Trial name
- NCT02624843
- Testing
- Benzyl Alcohol Lotion 5%, Ulesfia (benzyl alcohol lotion) 5%
- Where
- 4 sites in United States
- Volunteers
- 239 people, healthy volunteers welcome
- Sponsor
- Akorn, Inc.
Pediculosis
Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice
In this study, Malathion Gel 0.5% will be compared to Nix (permethrin 1%) as a treatment for head lice in patients 2 years of age and older. Malathion Gel 0.5% is a new formulation of an established head lice treatment.
- Trial name
- NCT00927472
- Testing
- Malathion gel 0.5%, Permethrin 1% rinse
- Where
- 2 sites in United States
- Volunteers
- 254 people
- Sponsor
- Sun Pharmaceutical Industries, Inc.
Head Lice
A Study Comparing the Safety and Efficacy of 0.5% Ivermectin Cream to Placebo in Lice Infested Subjects
The purpose of this study is to determine if 0.5% Ivermectin Cream is a safe and effective treatment for head lice infestations.
- Trial name
- LICE OUT (NCT01068158)
- Testing
- 0.5% Ivermectin Cream
- Where
- 7 sites in United States
- Volunteers
- 371 people
- Sponsor
- Topaz Pharmaceuticals Inc